Brief: Tetra & Mondias Jointly Announce Acquisition Of Tetra's Lumiera Unit By Mondias
July 23 (Reuters) - Tetra Bio Pharma Inc TBP.V :
* TETRA AND MONDIAS JOINTLY ANNOUNCE THE ACQUISITION OF
TETRA'S
SUBSIDIARY, LUMIERA, BY MONDIAS TO CREATE A NEW GROWTH PLATFORM
* TETRA BIO PHARMA - SIGNED BINDING LOI PURSUANT TO WHICH
MONDIAS
TO ACQUIRE CO'S UNIT LUMIERA HEALTH INNOVATION
* TETRA BIO PHARMA - MONDIAS TO ACQUIRE LUMIERA FOR MINIMUM
PURCHASE PRICE OF $1 MILLION & MAXIMUM PURCHASE PRICE OF $1.5
MILLION
Source text for Eikon: ID:nCNW1g7rWa
Further company coverage: TBP.V
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Tetra Bio Pharma
See all newsBrief: Tetra Bio Receives A Second Clarifax From Health Canada Regarding Reduvo Risk Management Plan
Brief: Tetra Bio-Pharma Announces Results Of Artificial Intelligence Study Of ARDS-003 Combined With Favipiravir
Brief: Tetra Bio-Pharma Provides Update On Patent Applications For Novel Therapeutic Ards-003
Brief: Tetra Bio-Pharma Provides Update On Patent Applications For Novel Therapeutic Ards-003
Brief: Tetra And Prepaire Jointly Apply To Barda For Funding